Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/12897
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPantic, Damjan-
dc.contributor.authorStojadinovic, Milorad-
dc.contributor.authorStojadinovic, Miroslav-
dc.date.accessioned2021-04-20T22:01:30Z-
dc.date.available2021-04-20T22:01:30Z-
dc.date.issued2020-03-01-
dc.identifier.issn18208665-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/12897-
dc.description.abstract© 2020, University of Kragujevac, Faculty of Science. All rights reserved. Serum prostate-specific antigen (PSA) testing increases the number of persons who undergo prostate biopsy. Howev-er, the best possible strategy for selecting patients for prostate biopsy has not yet been defined. The aim of this study was to develop a classification and regression tree (CART) decision model that can be used to predict significant prostate cancer (PCa) in the course of prostate biopsy for patients with serum PSA levels of 10 ng/ml or less. The following clinicopathological characteristics of patients who had undergone ultrasound-guided transrectal prostate biopsy were collected: age, PSA, digital rectal examination, volume of the prostate, and PSA density (PSAD). CART analysis was carried out by using all predictors. Different aspects of the predictive performances of the prediction model were assessed. In this retrospective study, significant PCa values were detected in 26 (26.8%) of a total of 97 patients. The CART model had three branching levels based on PSAD as the most decisive variable and age. The model sensitivity was 73.1%, the specificity was 80.3% and the accuracy was 78.3%. Our model showed an area under the receiver operating characteristic curve of 82.6%. The model was well calibrated. In conclusion, CART analysis determined that PSAD was the key parameter for the identification of patients with a minimal risk for positive biopsies. The model showed a good discrimination capacity that surpassed individual predic-tors. However, before recommending its use in clinical prac-tice, an evaluation of a larger and more complete database is necessary for the prediction of significant PCa.-
dc.relation.ispartofSerbian Journal of Experimental and Clinical Research-
dc.titleDecision tree analysis for prostate cancer prediction in patients with serum psa 10 NG/ML or less-
dc.typeArticle-
dc.identifier.doi10.2478/SJECR-2018-0039-
dc.identifier.scopus85088920533-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

[ Google Scholar ]

Page views(s)

57

Downloads(s)

2

Files in This Item:
File Description SizeFormat 
10.2478_sjecr-2018-0039.pdf449.57 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.